Cannabinoid compounds include exogenous drugs such as Δ⁹-THC, the main psychoactive component of the plant Cannabis sativa, and endogenous mediators, such as anandamide, that belong to eicosanoid family.The biological effects of cannabinoids are mediated by a family of two Gi-coupled 7-transmembrane receptors, CB₁ and CB₂. The CB₁ receptor is found primarily in brain and mediates the psychoactive effects of cannabinoid ligands. The CB₂ receptor is expressed mainly in immune cells, including mast cells and CD40-activated B cells, where it mediates proliferation and inhibition of migration (Howlett et al., 2002). Activation of CB₂ inhibits the development of liver fibrosis (Julien et al., 2005). In bone, CB₂ is expressed in both osteoblasts and osteoclasts, and functions to prevent bone loss (Ofek et al., 2006). In addition, activation of CB₂ has an antinociceptive effect in animal models of neuropathic, inflammatory, and acute pain; this effect is mediated by release of endogenous opioids in the periphery (Ibrahim et al., 2005).
Millipore's CB₂ Membrane Preparation for GTPγS Assay is a crude membrane preparation made from the proprietary stable recombinant cell line that is also used for Millipore’s CB₂ Calcium Optimized Cell Line (HTS020C). This CB₂ Membrane Preparation has been optimized for low basal activity in GTPγS binding assays; thus it is an ideal HTS tool for screening of compounds for agonist and antagonist activities. The membrane preparations exhibits EC50 of 13.7 nM for CP55,940 in a GTPγS binding assay. This CB₂ Membrane Preparation may also be used in radioligand binding assays.
Millipore offers another CB₂ Membrane Preparation (HTS020M) which has been optimized for high signal:background in radioligand binding assay, and also displays high constitutive activity that permits analysis of compounds for inverse agonist activity.